PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE 250

225.50p
   
  • Change Today:
    -1.00p
  • 52 Week High: 241.50
  • 52 Week Low: 140.40
  • Currency: UK Pounds
  • Shares Issued: 270.41m
  • Volume: 100,407
  • Market Cap: £609.78m

Income Statement - Unadjusted

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 3.33 15.62 17.39 11.77 9.81
           
EBITDA (30.19) (195.06) (56.72) 65.85 524.62
Depreciation & Amortisation (4.93) (8.89) (7.29) (6.64) n/a
           
Operating Profit/(Loss) (35.13) (203.96) (64.00) 59.20 524.62
Interest Payable (13.58) (3.94) (4.77) (7.30) (50.51)
Interest Receivable/Investment Income 18.66 142.86 9.82 1.18 4.36
           
Group Profit after Interest (30.05) (65.03) (58.95) 53.09 478.47
Share of Assoc Cos/JV Profits (6.05) (27.75) n/a (34.12) n/a
           
Profit Before Tax (36.10) (92.78) (58.95) 18.97 478.47
Tax (30.52) 55.72 (3.76) (14.40) (112.41)
           
Profit After Tax (66.63) (37.06) (62.71) 4.57 366.07
           
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
           
PROFIT FOR THE PERIOD (66.63) (37.06) (62.71) 4.57 366.07
           
Attributable to:          
Equity Shareholders' Earnings (65.54) (50.35) (60.56) 5.99 421.14
Minority interests (0.93) 13.29 (2.15) (1.42) (55.08)
           
Equity Dividends cn/a cn/a cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year cn/a cn/a cn/a cn/a cn/a


Per Share Record - Unadjusted 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing EPS          
Earnings per Share - Basic (24.00¢) (18.00¢) (21.00¢) 2.00¢ 149.00¢
Earnings per Share - Diluted (24.00¢) (18.00¢) (21.00¢) 2.00¢ 144.00¢
Continuing and Discontinued EPS          
Earnings per Share - Basic (24.00¢) (18.00¢) (21.00¢) 2.00¢ 149.00¢
Earnings per Share - Diluted (24.00¢) (18.00¢) (21.00¢) 2.00¢ 144.00¢
           
Dividend per Share n/a n/a n/a n/a n/a


Key Financals 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Shares in Issue (millions)          
Shares in Issue - Year End 271.85 278.57 287.80 285.89 285.37
Weighted Average 276.30 284.76 286.59 285.60 283.43
Diluted 276.30 284.76 286.59 285.60 291.78
           
Performance Ratios          
Continuing Operations          
Operating Margin (1,054.86%) (1,305.91%) (368.09%) 503.06% 5,349.45%
Tax Rate (101.59%) 85.68% (6.37%) 27.13% 23.49%
Return on Capital Employed n/a n/a n/a 2.62% 57.94%
Continuing Operations & Discontinued Operations          
Return on Equity (ROE) (12.69%) (8.96%) (0.09%) 0.77% 53.75%
           
Financial Status          
Continuing Operations          
Interest Cover (1.66) (22.55) (11.36) 3.60 10.47
Revenue per Share 1.21¢ 5.49¢ 0.061¢ 4.12¢ 3.46¢
Pre-Tax Profit per Share (13.07¢) (32.58¢) (0.21¢) 6.64¢ 168.82¢
           
Market Data          
Continuing Operations          
Earnings per Share Growth - Basic n/a n/a n/a -99% n/a
Earnings per Share Growth - Adjusted n/a n/a n/a -99% n/a
Earnings per Share Growth - Diluted n/a n/a n/a -99% n/a
PE Ratio - Adjusted n/a n/a n/a 254.3 2.7
PEG - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Continuing Operations & Discontinued Operations          
Earnings per Share Growth - Basic n/a n/a n/a -99% n/a
Earnings per Share Growth - Adjusted n/a n/a n/a -99% n/a
Earnings per Share Growth - Diluted n/a n/a n/a -99% n/a
PE Ratio - Adjusted n/a n/a n/a 254.3 2.7
PEG - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
           
Market Capitalisation $ (Millions) 527.94 742.38 840.37 1,143.54 913.19
Dividend per Share n/a n/a n/a n/a n/a
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page